Alec Spinelli – an Author and Educator
Table of Contents
Tell us about your background and your motivation behind writing these series of books.
Alec Spinelli is a seasoned Clinical Research Author, Clinical Project Manager, Clinical Educator and Speaker with nearly 20 years of clinical research industry experience and 26 years in healthcare. He has led global trials across Phases IโIV and held key roles at sponsor and CRO companies, including Sr. CRA, Lead CRA, Clinical Trial Manager, Clinical Team Lead, and Project Manager. He is currently a Start-up Project Manager at Fortrea CRO.
Alec holds an MBA in Business Management from Liberty University, completed his graduate studies in Biomedical Engineering at Rutgers University, and earned a B.A. in Biology. His blend of hands-on experience, academic insight, and investment in continuing education make his books an essential resource to understanding and navigating clinical research for patients, families, and clinical research professionals at all levels.
My motivation for writing my clinical research book series came from years of answering questions from colleagues and LinkedIn connections about career growth, ICH-GCP, regulatory compliance, and clinical trial operations. I wanted to create practical, concise resources that simplify complex topics and help professionals confidently navigate and advance within clinical research.
You can see all current books available for purchase on Amazon:
(Back to the Contents) (Back to the Top)
Why do you think the clinical research industry still has such low visibility despite its enormous impact?
I think clinical research often carries an air of mystery, making it seem inaccessible to those unfamiliar with the field. Many people have never heard of clinical research or interacted with it until a family member, close friend, or loved one becomes sick and begins exploring treatment options. At that moment, clinical research can suddenly become very personal.
People also assume it requires a medical degree or years of specialized training, but the truth is far more inclusive. Clinical research welcomes professionals from diverse backgrounds, offering pathways for individuals with experience in healthcare, science, and even nontraditional fields to contribute meaningfully to advancing medicine.
(Back to the Contents) (Back to the Top)
Why is it so difficult for candidates to land that first clinical research role?
One of the fundamental challenges in entering the clinical research field is the competitive nature of the job market. With so many individuals seeking to break into this rewarding profession, it’s essential to differentiate yourself.
Knowing about the industry is only half the battle. The other half lies in preparation, where developing the skills, gaining the experience, and crafting the narrative you need to make employers see you as a perfect fit.
From understanding the foundational knowledge required for clinical research roles, including specific therapeutic area, regulatory, start-up, clinical operations, data management, etc., to crafting a resume highlighting your most relevant strengths, and ways to leverage your existing skills, even if your background isn’t directly in clinical research.
These are factors that must be addressed when seeking to break into a first-time clinical research role.
(Back to the Contents)(Back to the Top)
What do hiring managers prioritize versus what applicants think matters in terms of someoneโs CV and skills?
Many applicants believe hiring managers only focus on certifications, titles, or years of experience, but hiring managers often prioritize quantifiable results, adaptability, communication, reliability, problem-solving, and whether someone can work effectively within cross functional team.
A strong CV certainly matters, but employers also look for candidates who understand clinical trial operations, can think critically, and demonstrate professionalism. In clinical research especially, attitude, responsiveness, and the ability to learn and adapt quickly can sometimes outweigh having a great background on paper. More recently, hiring managers are also looking for the ability to utilize AI tools and systems effectively to execute trials successfully.
(Back to the Contents)(Back to the Top)
What do people misunderstand most about the Clinical Research Associate (CRA) role before entering it?
I think one of the biggest misunderstandings about the CRA role is that people think it is mostly travel and site visits. Another very frequent misconception is that it is an entry-level position.
In reality, the CRA role typically requires prior clinical research experience and a strong understanding of monitoring, trial oversight, regulations, and site operations.
While travel can be a major part of the role, CRAs are also responsible for communication, documentation review, problem-solving, and protecting patient safety and data integrity. Success often depends on organization, adaptability, critical thinking, and the ability to manage complex relationships across multiple studies and sites.
(Back to the Contents) (Back to the Top)
What is the biggest mindset shift when moving from CRA to Clinical Trial Manager (CTM)?
One of the biggest mindset shifts when moving from a CRA to a CTM role is transitioning from primarily overseeing individual tasks and sites to leading the broader strategy and execution of an entire clinical trial.
A CRA often focuses on monitoring and site-level oversight, while a CTM must think more globally across timelines, budgets, vendors, cross-functional teams, and operational risks. The role requires stronger leadership, communication, and decision-making skills, along with the ability to balance competing priorities while keeping the study moving forward efficiently and compliantly.
(Back to the Contents) (Back to the Top)
What do you see as the most important philosophical shift in ICH-GCP E6(R3)?
I believe the most important philosophical shift in ICH-GCP E6(R3) is the stronger emphasis on Quality by Design (QbD) and proactive risk management rather than relying heavily on retrospective correction and excessive documentation.
The updated guidance encourages organizations to build quality into clinical trials from the beginning by focusing on critical processes, patient safety, and data integrity.
It reflects a more modern, flexible, and practical approach to trial oversight that better supports innovation, decentralized trials, technology integration, and real-world operational challenges across global clinical research.
(Back to the Contents) (Back to the Top)
Has informed consent become too complex for the average patient?
I believe informed consent forms (ICFs) have become far too complex for the average patient and even overwhelming for many experienced healthcare professionals.
While the intent is to protect patients and ensure transparency, many ICFs are now filled with dense legal, medical, and regulatory language that can make true understanding difficult.
Patients are often reviewing these documents during stressful and emotional moments in their lives. That was one of the main motivations behind writing my book, โInformed Consent Made Simple.โ I wanted to create a practical resource that helps patients, families, and professionals better understand the purpose, process, and real-world importance of informed consent in clinical research.
(Back to the Contents) (Back to the Top)
How do you think AI will reshape clinical operations over the next five years?
I believe AI will significantly reshape clinical operations over the next five years by helping augment many routine, simple, and time-consuming tasks.
AI systems will likely assist with the Trial Master File (TMF) index construction and review, protocol summarization and analysis for site ID, and first-pass QC reviews of essential records, helping reduce administrative burden and improve efficiency.
Rather than replacing clinical research professionals, I believe the workforce will shift its focus toward more complex responsibilities involving oversight, strategy, decision-making, relationship management, and patient-centered activities that still require strong human judgment and experience.
(Back to the Contents) (Back to the Top)
If someone wants to enter clinical research this year, what should they do first?
If someone wants to enter clinical research this year, the first thing they should do is review the top entry-level research roles and identify which pathway best aligns with their background, interests, strengths, and long-term goals.
Not every entry point is the same, and understanding where they fit best is critical. Next, they should build a strong foundation in general clinical research knowledge and then focus specifically on the responsibilities and expectations of their desired role.
This helps them craft a targeted resume that highlights transferable skills, relevant strengths, and how their existing experience can provide value to the company and clinical trial team. They should also ensure they understand use and application of AI in clinical research as this is becoming an increasingly essential skill in our industry.
(Back to the Contents) (Back to the Top)
We’d like to thank Alec for sharing his resources and expertise to the S.P.I.R.I.T. community!
Leave a Reply